27741201|t|Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate
27741201|a|To examine the differences in perinatal outcomes among women with a prior preterm birth who received cerclage compared with cerclage plus 17α-hydroxyprogesterone caproate. Women with transvaginal cerclage placement and a prior delivery between 16 and 36 weeks of gestation were identified over a 10- year period (July 2002 to May 2012) in this retrospective cohort study. Exclusion criteria were delivery at another institution, abdominal cerclage, multiple gestations, and major fetal anomalies. Maternal demographics, gestational age at cerclage, gestational age at delivery, preterm prelabor rupture of membranes (PROM), and birth weight were compared between women with a cerclage and cerclage plus 17α-hydroxyprogesterone caproate. The primary outcome was delivery at less than 24 weeks of gestation. Of the 411 women who had a cerclage, 260 met inclusion criteria. Of these, 171 received a cerclage alone and 89 received cerclage plus 17α-hydroxyprogesterone caproate. The two groups were not different with respect to maternal demographics and gestational age at cerclage. There was a significant difference among those who received indomethacin at the time of cerclage, betamethasone administration, and history of a loop electrosurgical excision procedure - cold knife cone and cerclage. Delivery at less than 24 weeks of gestation occurred in 6% of women receiving both 17α-hydroxyprogesterone caproate and cerclage compared with 16% in the cerclage only group (odds ratio [OR] 0.31, 95% confidence interval 0.10-0.78, P=.01). In the multivariate analysis controlling for indomethacin use, prior cerclage, and loop electrosurgical excision procedure - cold knife cone there was a 73% reduction in delivery in the combined treatment group compared with cerclage alone (adjusted OR 0.26, P=.02). A multivariant analysis was conducted with correction for indomethacin at the time of cerclage, prior cerclage, and loop electrosurgical excision procedure - cold knife cone and cerclage surgery. Even after controlling for significant variables, there remained a 73% reduction in delivery at less than 24 weeks of gestation in the cerclage plus 17α-hydroxyprogesterone caproate cohort (adjusted OR 0.26, P=.02). Women receiving transvaginal cerclage plus 17α-hydroxyprogesterone caproate had a 69% relative reduction in delivery at less than 24 weeks of gestation when compared with women receiving cerclage alone. We found no difference in overall preterm delivery or preterm PROM. In this cohort, compared with cerclage alone, the likelihood of a viable neonate improves with both treatments.
27741201	0	8	Outcomes	T169	C1274040
27741201	14	22	Cerclage	T061	C0994592
27741201	29	37	Compared	T052	C1707455
27741201	43	51	Cerclage	T061	C0994592
27741201	57	89	17α-Hydroxyprogesterone Caproate	T109,T121,T125	C0044971
27741201	105	116	differences	T080	C1705242
27741201	120	138	perinatal outcomes	T169	C1274040
27741201	145	150	women	T098	C0043210
27741201	164	177	preterm birth	T033	C0151526
27741201	191	199	cerclage	T061	C0994592
27741201	200	208	compared	T052	C1707455
27741201	214	222	cerclage	T061	C0994592
27741201	228	260	17α-hydroxyprogesterone caproate	T109,T121,T125	C0044971
27741201	262	267	Women	T098	C0043210
27741201	273	294	transvaginal cerclage	T061	C0994592
27741201	311	325	prior delivery	UnknownType	C0747969
27741201	344	349	weeks	T079	C0439230
27741201	353	362	gestation	T040	C0032961
27741201	390	394	year	T079	C0439234
27741201	395	401	period	T079	C1948053
27741201	434	460	retrospective cohort study	T062	C2985505
27741201	462	480	Exclusion criteria	T169	C0680251
27741201	486	494	delivery	T040	C0005615
27741201	506	517	institution	T073,T093	C0018704
27741201	519	537	abdominal cerclage	T061	C1292825
27741201	539	558	multiple gestations	T033	C0032989
27741201	570	575	fetal	T018	C0015965
27741201	576	585	anomalies	T033	C1704258
27741201	587	595	Maternal	T099	C0026591
27741201	596	608	demographics	T081	C2828391
27741201	610	625	gestational age	T032	C0017504
27741201	629	637	cerclage	T061	C0994592
27741201	639	654	gestational age	T032	C0017504
27741201	658	666	delivery	T040	C0005615
27741201	668	705	preterm prelabor rupture of membranes	T046	C0015944
27741201	707	711	PROM	T046	C0015944
27741201	718	730	birth weight	T032	C0005612
27741201	736	744	compared	T052	C1707455
27741201	753	758	women	T098	C0043210
27741201	766	774	cerclage	T061	C0994592
27741201	779	787	cerclage	T061	C0994592
27741201	793	825	17α-hydroxyprogesterone caproate	T109,T121,T125	C0044971
27741201	839	846	outcome	T169	C1274040
27741201	851	859	delivery	T040	C0005615
27741201	873	894	24 weeks of gestation	T033	C0730522
27741201	907	912	women	T098	C0043210
27741201	923	931	cerclage	T061	C0994592
27741201	941	959	inclusion criteria	T080	C1512693
27741201	986	994	cerclage	T061	C0994592
27741201	1017	1025	cerclage	T061	C0994592
27741201	1031	1063	17α-hydroxyprogesterone caproate	T109,T121,T125	C0044971
27741201	1073	1079	groups	T098	C0043210
27741201	1115	1123	maternal	T099	C0026591
27741201	1124	1136	demographics	T081	C2828391
27741201	1141	1156	gestational age	T032	C0017504
27741201	1160	1168	cerclage	T061	C0994592
27741201	1230	1242	indomethacin	T109,T121	C0021246
27741201	1258	1266	cerclage	T061	C0994592
27741201	1268	1281	betamethasone	T109,T121,T125	C0005308
27741201	1282	1296	administration	T061	C1533734
27741201	1302	1354	history of a loop electrosurgical excision procedure	T033	C4039811
27741201	1357	1372	cold knife cone	T060	C0195325
27741201	1377	1385	cerclage	T061	C0994592
27741201	1387	1395	Delivery	T040	C0005615
27741201	1409	1430	24 weeks of gestation	T033	C0730522
27741201	1449	1454	women	T098	C0043210
27741201	1470	1502	17α-hydroxyprogesterone caproate	T109,T121,T125	C0044971
27741201	1507	1515	cerclage	T061	C0994592
27741201	1516	1524	compared	T052	C1707455
27741201	1541	1549	cerclage	T061	C0994592
27741201	1555	1560	group	T098	C0043210
27741201	1562	1572	odds ratio	T081	C0028873
27741201	1574	1576	OR	T081	C0028873
27741201	1588	1607	confidence interval	T081	C0009667
27741201	1634	1655	multivariate analysis	T081	C0026777
27741201	1672	1684	indomethacin	T109,T121	C0021246
27741201	1696	1704	cerclage	T061	C0994592
27741201	1710	1749	loop electrosurgical excision procedure	T061	C0184930
27741201	1752	1767	cold knife cone	T060	C0195325
27741201	1797	1805	delivery	T040	C0005615
27741201	1832	1837	group	T098	C0043210
27741201	1838	1846	compared	T052	C1707455
27741201	1852	1860	cerclage	T061	C0994592
27741201	1877	1879	OR	T081	C0028873
27741201	1896	1917	multivariant analysis	T062	C0936012
27741201	1952	1964	indomethacin	T109,T121	C0021246
27741201	1980	1988	cerclage	T061	C0994592
27741201	1996	2004	cerclage	T061	C0994592
27741201	2010	2049	loop electrosurgical excision procedure	T061	C0184930
27741201	2052	2067	cold knife cone	T060	C0195325
27741201	2072	2080	cerclage	T061	C0994592
27741201	2081	2088	surgery	T061	C0543467
27741201	2174	2182	delivery	T040	C0005615
27741201	2196	2217	24 weeks of gestation	T033	C0730522
27741201	2225	2233	cerclage	T061	C0994592
27741201	2239	2271	17α-hydroxyprogesterone caproate	T109,T121,T125	C0044971
27741201	2272	2278	cohort	T098	C0599755
27741201	2289	2291	OR	T081	C0028873
27741201	2306	2311	Women	T098	C0043210
27741201	2322	2343	transvaginal cerclage	T061	C0994592
27741201	2349	2381	17α-hydroxyprogesterone caproate	T109,T121,T125	C0044971
27741201	2414	2422	delivery	T040	C0005615
27741201	2436	2457	24 weeks of gestation	T033	C0730522
27741201	2463	2471	compared	T052	C1707455
27741201	2477	2482	women	T098	C0043210
27741201	2493	2501	cerclage	T061	C0994592
27741201	2543	2559	preterm delivery	T033	C0151526
27741201	2563	2575	preterm PROM	T046	C0015944
27741201	2585	2591	cohort	T098	C0599755
27741201	2593	2601	compared	T052	C1707455
27741201	2607	2615	cerclage	T061	C0994592
27741201	2650	2657	neonate	T100	C0021289
27741201	2677	2687	treatments	T061	C0087111